A study of the use of clozapine in old age psychiatry

International Clinical Psychopharmacology

Volumn 26, Issue 4, 2011, Pages 232-235

  Snowdon, John ^a   Halliday, Graeme ^a  

^a ANZAC Research Institute   (Australia)

Author keywords

Clozapine; Neutropenia; Old age; Outcome

Indexed keywords

CLOZAPINE; VALPROIC ACID;

AGED; ARTICLE; CLINICAL ARTICLE; DEMENTIA; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH SERVICE; HOSPITAL DISCHARGE; HUMAN; MALE; NEUTROPENIA; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SENESCENCE;

AGE OF ONSET; AGED; CLOZAPINE; DEMENTIA; DRUG UTILIZATION; FEMALE; HUMANS; INPATIENTS; MALE; MENTAL DISORDERS; MIDDLE AGED; NEUTROPENIA; NEW SOUTH WALES; PSYCHIATRY; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 80051545245     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32834405fc     Document Type: Article

References (13)

1. Atkin K, Kendall F, Gould D, Freeman H, Lieberman J, O'Sullivan D (1996). Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Brit J Psychiatry 169:483-488.
2. Azorin J-M, Spiegel R, Remington G, Vanelle J-M, Pé ré J-J, Giguere M, et al. (2001). A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia. Am J Psychiatry 158:1305-1313. (Pubitemid 32717707)
3. Castle D, Lambert T, Melbourne S, Cox A, Boardman G, Fairest K, et al. (2006). A clinical monitoring system for clozapine. Australasian Psychiatry 14: 156-168. (Pubitemid 44349328)
4. Herst L, Powell G (1997). Is clozapine safe in the elderly? Aust N Z J Psychiatry 31:411-417. (Pubitemid 27353108)
5. Howanitz E, Pardo M, Smelson D, Engelhart C, Eisenstein N, Losonczy MF (1999). The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry 60:41-44. (Pubitemid 29069885)
6. Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker WW (1994). Clozapineinduced transient white blood count disorders. J Clin Psychiatry 55:429-432.
7. Jeste DV, Dolder CR, Nayak GV, Salzman C (2005). Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature. Harvard Rev Psychiatry 13:340-351. (Pubitemid 43048618)
8. Klein C, Gordon J, Pollak L, Rabey JM (2003). Clozapine in Parkinson's disease psychosis: 5-year follow-up review. Clin Neuropharmacol 26:8-11. (Pubitemid 36184109)
9. Lee HB, Hanner JA, Yokley JL, Appleby B, Hurowitz L, Lyketsos CG (2007). Clozapine for treatment-resistant agitation in dementia. J Geriatr Psychiatry Neurol 20:178-182. (Pubitemid 47231223)
10. Merims D, Meirav B, Peretz C, Shabtai H, Giladi N (2006). Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis. Clin Neuropharmacol 29:331-337. (Pubitemid 44729944)
11. Merrill DB, Dec GW, Goff DC (2005). Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol 25:32-41. (Pubitemid 40129380)
12. O'Connor DW, Sierakowski C, Chin LF, Singh D (2010). The safety and tolerability of clozapine in aged patients: a retrospective clinical file review. World J Biolog Psychiatry 11:788-791.
13. Paranthaman R, Baldwin RC (2006). Survey of clozapine use by consultant old age psychiatrists. Psychiatr Bull 30:410-412. (Pubitemid 44680331)